Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings
J Konishi, K Yamazaki, E Tsukamoto, N Tamaki… - Respiration, 2003 - karger.com
Background: Accurate staging of mediastinal and hilar lymph nodes is a critical factor
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings
J Konishi, K Yamazaki, E Tsukamoto, N Tamaki… - Respiration, 2003 - cir.nii.ac.jp
抄録< jats: p> Background: Accurate staging of mediastinal and hilar lymph nodes is a
critical factor determining operability in patients with non-small cell lung cancer (NSCLC) …
critical factor determining operability in patients with non-small cell lung cancer (NSCLC) …
Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings
J Konishi, K Yamazaki, E Tsukamoto, N Tamaki… - …, 2003 - search.proquest.com
Accurate staging of mediastinal and hilar lymph nodes is a critical factor determining
operability in patients with non-small cell lung cancer (NSCLC). Positron emission …
operability in patients with non-small cell lung cancer (NSCLC). Positron emission …
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings.
J Konishi, K Yamazaki, E Tsukamoto… - … Review of Thoracic …, 2003 - europepmc.org
Accurate staging of mediastinal and hilar lymph nodes is a critical factor determining
operability in patients with non-small cell lung cancer (NSCLC). Positron emission …
operability in patients with non-small cell lung cancer (NSCLC). Positron emission …
[引用][C] Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: Analysis of false-positive FDG-PET findings
J KONISHI, K YAMAZAKI, E TSUKAMOTO… - Respiration …, 2003 - pascal-francis.inist.fr
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer:
Analysis of false-positive FDG-PET findings CNRS Inist Pascal-Francis CNRS Pascal and …
Analysis of false-positive FDG-PET findings CNRS Inist Pascal-Francis CNRS Pascal and …
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings
J Konishi, K Yamazaki, E Tsukamoto… - … review of thoracic …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Accurate staging of mediastinal and hilar lymph nodes is a critical factor
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
Mediastinal Lymph Node Staging by FDG-PET in Patients with Non-Small Cell Lung Cancer: Analysis of False-Positive FDG-PET Findings
J Konishi, K Yamazaki, E Tsukamoto, N Tamaki… - Respiration, 2003 - karger.com
Background: Accurate staging of mediastinal and hilar lymph nodes is a critical factor
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
determining operability in patients with non-small cell lung cancer (NSCLC). Positron …
[引用][C] Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer: analysis of false-positive FDG-PET findings
J KONISHI - Respiration, 2003 - cir.nii.ac.jp
Mediastinal lymph node staging by FDG-PET in patients with non-small cell lung cancer :
analysis of false-positive FDG-PET findings | CiNii Research CiNii 国立情報学研究所 学術情報 …
analysis of false-positive FDG-PET findings | CiNii Research CiNii 国立情報学研究所 学術情報 …